Clinical Trials Browser

Phase 2 × Lung Neoplasms × MAC321 × Clear all

NCT00063219 2009-08-21

Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms